Tru Singular Health, Inc. — SEC Form D Filing
Tru Singular Health, Inc. filed an SEC Form D on October 30, 2026, reporting $1.00M raised in Biotechnology.
Form D filing details
- Filing
- SEC Form D
- Filing date
- October 30, 2026
- Amount reported
- $1.00M
- Round stage
- Seed stage based on the $1,000,000 raised via Simple Agreements for Future Equity to fund early technical development.
- Industry
- Biotechnology
- Website
- https://www.trusingular.com
What the company does
Securities: Simple Agreements for Future Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Conventional biotech research struggles with high failure rates and inefficient discovery workflows in targeted therapeutic development.
Solution
Tru Singular Health builds novel biotechnology solutions to accelerate precision drug discovery and candidate development.
Why now
Recent breakthroughs in computational biology and functional genomics enable highly targeted therapeutic discovery at a fraction of historical costs.
Source: SEC EDGAR Form D filing